• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Combined anti-inflammatory and low-dose antiproliferative therapy for squamous cell carcinomas in recessive dystrophic epidermolysis bullosa.

作者信息

Reimer A, Lu S, He Y, Bruckner-Tuderman L, Technau-Hafsi K, Meiss F, Has C, von Bubnoff D

机构信息

Department of Dermatology, Faculty of Medicine, Medical Center - University of Freiburg, Freiburg, Germany.

Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

出版信息

J Eur Acad Dermatol Venereol. 2020 Jan;34(1):e1-e3. doi: 10.1111/jdv.15835. Epub 2019 Sep 2.

DOI:10.1111/jdv.15835
PMID:31374134
Abstract
摘要

相似文献

1
Combined anti-inflammatory and low-dose antiproliferative therapy for squamous cell carcinomas in recessive dystrophic epidermolysis bullosa.联合抗炎和低剂量抗增殖疗法治疗隐性营养不良性大疱性表皮松解症中的鳞状细胞癌。
J Eur Acad Dermatol Venereol. 2020 Jan;34(1):e1-e3. doi: 10.1111/jdv.15835. Epub 2019 Sep 2.
2
Use of cetuximab as an adjuvant agent to radiotherapy and surgery in recessive dystrophic epidermolysis bullosa with squamous cell carcinoma.西妥昔单抗在隐性营养不良性大疱性表皮松解症伴鳞状细胞癌中作为放疗和手术辅助药物的应用。
Br J Dermatol. 2013 Jul;169(1):208-10. doi: 10.1111/bjd.12272.
3
Pembrolizumab for Treatment of a Patient With Multiple Cutaneous Squamous Cell Carcinomas and Recessive Dystrophic Epidermolysis Bullosa.帕博利珠单抗治疗多发性皮肤鳞状细胞癌合并隐性营养不良性大疱性表皮松解症患者
JAMA Dermatol. 2020 Jun 1;156(6):708-710. doi: 10.1001/jamadermatol.2020.0304.
4
Cemiplimab treatment of squamous cell carcinoma in a patient with severe recessive dystrophic epidermolysis bullosa.西米普利单抗治疗重度隐性营养不良性大疱性表皮松解症患者的鳞状细胞癌
J Dtsch Dermatol Ges. 2023 Mar;21(3):295-297. doi: 10.1111/ddg.14980. Epub 2023 Feb 28.
5
Wound healing deficits in severe generalized recessive dystrophic epidermolysis bullosa along anticancer treatment with cetuximab.重度泛发性隐性营养不良性大疱性表皮松解症患者在接受西妥昔单抗抗癌治疗时的伤口愈合缺陷
J Dtsch Dermatol Ges. 2019 Apr;17(4):448-450. doi: 10.1111/ddg.13802. Epub 2019 Mar 1.
6
Good clinical response to cemiplimab in a young patient with locally advanced cutaneous squamous cell carcinoma on preexisting recessive dystrophic epidermolysis bullosa.在患有先天隐性营养不良性大疱性表皮松解症的年轻患者中，西普单抗治疗局部晚期皮肤鳞状细胞癌取得良好临床反应。
Acta Dermatovenerol Alp Pannonica Adriat. 2024 Sep;33(3):145-149.
7
[Squamous cell carcinoma and recessive dystrophic epidermolysis bullosa].[鳞状细胞癌与隐性营养不良型大疱性表皮松解症]
Ann Dermatol Venereol. 1992;119(8):563-5.
8
EGFR inhibition for metastasized cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa.表皮松解性营养不良型大疱性表皮松解症转移性皮肤鳞状细胞癌的表皮生长因子受体抑制作用。
Orphanet J Rare Dis. 2019 Dec 3;14(1):278. doi: 10.1186/s13023-019-1262-7.
9
Electrochemotherapy, a potential new treatment for the management of squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa: report of three cases.
J Eur Acad Dermatol Venereol. 2016 Jul;30(7):1195-6. doi: 10.1111/jdv.13116. Epub 2015 Mar 10.
10
Cetuximab therapy of metastasizing cutaneous squamous cell carcinoma in a patient with severe recessive dystrophic epidermolysis bullosa.西妥昔单抗治疗一名患有严重隐性营养不良性大疱性表皮松解症患者的转移性皮肤鳞状细胞癌。
Dermatology. 2009;219(1):80-3. doi: 10.1159/000218714. Epub 2009 May 13.

引用本文的文献

1
Therapies for cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: a systematic review of 157 cases.隐性营养不良型大疱性表皮松解症皮肤鳞状细胞癌的治疗：157 例系统性回顾。
Orphanet J Rare Dis. 2024 May 21;19(1):206. doi: 10.1186/s13023-024-03190-1.
2
Epidermolysis-Bullosa-Associated Squamous Cell Carcinomas Support an Immunosuppressive Tumor Microenvironment: Prospects for Immunotherapy.大疱性表皮松解症相关鳞状细胞癌支持免疫抑制性肿瘤微环境：免疫治疗的前景
Cancers (Basel). 2024 Jan 22;16(2):471. doi: 10.3390/cancers16020471.
3
Variable Outcome of Immunotherapy in Advanced Multiple Cutaneous Squamous Cell Carcinomas in Two Patients with Recessive Dystrophic Epidermolysis Bullosa.
两名隐性营养不良型大疱性表皮松解症患者晚期多发性皮肤鳞状细胞癌的免疫治疗结果不同。
Acta Derm Venereol. 2023 Jun 20;103:adv4870. doi: 10.2340/actadv.v103.4870.
4
Investigational Treatments for Epidermolysis Bullosa.表皮松解性水疱症的治疗研究。
Am J Clin Dermatol. 2021 Nov;22(6):801-817. doi: 10.1007/s40257-021-00626-3. Epub 2021 Jul 22.
5
Cutaneous Squamous Cell Carcinoma in Epidermolysis Bullosa: a 28-year Retrospective Study.大疱性表皮松解症相关皮肤鳞癌：28 年回顾性研究。
Acta Derm Venereol. 2021 Aug 24;101(8):adv00523. doi: 10.2340/00015555-3875.
6
Small molecule drug development for rare genodermatoses - evaluation of the current status in epidermolysis bullosa.罕见遗传性皮肤病小分子药物研发——大疱性表皮松解症现状评估。
Orphanet J Rare Dis. 2020 Oct 19;15(1):292. doi: 10.1186/s13023-020-01467-9.
7
Molecular Therapeutics in Development for Epidermolysis Bullosa: Update 2020.正在开发中的用于大疱性表皮松解症的分子疗法：2020 年更新。
Mol Diagn Ther. 2020 Jun;24(3):299-309. doi: 10.1007/s40291-020-00466-7.
8
Epidermolysis Bullosa-Associated Squamous Cell Carcinoma: From Pathogenesis to Therapeutic Perspectives.大疱性表皮松解症相关鳞状细胞癌：从发病机制到治疗观点。
Int J Mol Sci. 2019 Nov 14;20(22):5707. doi: 10.3390/ijms20225707.